{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:33:50Z","timestamp":1792154030542,"version":"4.4.0"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic cardiomyopathy (DCM), one of the common complications of diabetes, presents as a specific cardiomyopathy with anomalies in the structure and function of the heart. With the increasing prevalence of diabetes, DCM has a high morbidity and mortality worldwide. Recent studies have found that pyroptosis, as a programmed cell death accompanied by an inflammatory response, exacerbates the growth and genesis of DCM. These studies provide a theoretical basis for exploring the potential treatment of DCM. Therefore, this review aims to summarise the possible mechanisms by which pyroptosis promotes the development of DCM as well as the relevant studies targeting pyroptosis for the possible treatment of DCM, focusing on the molecular mechanisms of NLRP3 inflammasome-mediated pyroptosis, different cellular pyroptosis pathways associated with DCM, the effects of pyroptosis occurring in different cells on DCM, and the relevant drugs targeting NLRP3 inflammasome\/pyroptosis for the treatment of DCM. This review might provide a fresh perspective and foundation for the development of therapeutic agents for DCM.<\/jats:p>","DOI":"10.3389\/fendo.2023.1322907","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:31:13Z","timestamp":1704429073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Role of pyroptosis in diabetic cardiomyopathy: an updated review"],"prefix":"10.3389","volume":"14","author":[{"given":"Gan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Juan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11886-019-1107-y","article-title":"Epidemiology of diabetes mellitus and cardiovascular disease","volume":"21","author":"Glovaci","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - A comprehensive updated review","volume":"62","author":"Murtaza G, Virk HUH, Khalid M, Lavie CJ, Ventura H, Mukherjee D","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"B3","unstructured":"Nature Reviews Disease PrimersType 1 diabetes mellitus"},{"key":"B4","unstructured":"Nature Reviews Molecular Cell BiologyMolecular and metabolic mechanisms of insulin resistance and \u03b2-cell failure in type 2 diabetes"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"B6","unstructured":"SpringerLinkDiabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122136","article-title":"Diabetic cardiomyopathy: does the type of diabetes matter","volume":"17","author":"H\u00f6lscher","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Failure Clinics"},{"key":"B11","unstructured":"Diabetes, cardiomyopathy, and heart failure\n            OktayAA\n            PaulTK\n            KochCA\n            LavieCJ\n          MDText.com, IncEndotext2023"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail Rev"},{"key":"B14","unstructured":"Ingenta ConnectDiabetic Cardiomyopathy: From Mechanism to Management in a Nutshell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12250","article-title":"Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage","volume":"5","author":"Liu","year":"","journal-title":"J Diabetes Invest"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00042","article-title":"Distinct types of cell death and the implication in diabetic cardiomyopathy","volume":"11","author":"Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G","year":"","journal-title":"Front Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2021.08.026","article-title":"Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy","volume":"12","author":"Wei","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.23736\/s2724-5683.20.05454-7","article-title":"Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage","volume":"70","author":"Elia","year":"2022","journal-title":"Minerva Cardiol Angiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"20420188221083530","DOI":"10.1177\/20420188221083530","article-title":"Role of inflammation in diabetic cardiomyopathy","volume":"13","author":"Ramesh","year":"2022","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13453","article-title":"Chronic low-grade inflammation in heart failure with preserved ejection fraction","volume":"20","author":"Mesquita","year":"2021","journal-title":"Aging Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e12563","DOI":"10.1111\/cpr.12563","article-title":"Role of pyroptosis in cardiovascular disease","volume":"52","author":"Zhaolin","year":"2019","journal-title":"Cell Proliferation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167301","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"434","author":"Wei","year":"2022","journal-title":"J Mol Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-00998-3","article-title":"Cell pyroptosis in health and inflammatory diseases","volume":"8","author":"Wu","year":"2022","journal-title":"Cell Death Discovery"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: effectors of pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/thno.62521","article-title":"Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment","volume":"11","author":"Hsu","year":"2021","journal-title":"Theranostics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cr.2017.133","article-title":"Plasma membrane changes during programmed cell deaths","volume":"28","author":"Zhang","year":"2018","journal-title":"Cell Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.08.021","article-title":"Caspases and kinases in a death grip","volume":"138","author":"Kurokawa","year":"2009","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Sig Transduct Target Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(96)00159-8","article-title":"Nuclear factor-\u03baB","volume":"29","author":"Barnes","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-\u03baB activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2012.01108.x","article-title":"Ubiquitination in signaling to and activation of IKK","volume":"246","author":"Chen","year":"2012","journal-title":"Immunol Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00071","article-title":"Regulation of the NF-\u03baB-mediated transcription of inflammatory genes","volume":"5","author":"Bhatt","year":"2014","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117138","article-title":"A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications","volume":"240","author":"Yu","year":"2020","journal-title":"Life Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810632","article-title":"NLRP3 inflammasome\/pyroptosis: A key driving force in diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.100","article-title":"Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167246","article-title":"Regulation of lytic and non-lytic functions of gasdermin pores","volume":"434","author":"R\u00fchl","year":"2022","journal-title":"J Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"151884","DOI":"10.1016\/j.imbio.2019.11.019","article-title":"Research progresses of molecular mechanism of pyroptosis and its related diseases","volume":"225","author":"Gong","year":"2020","journal-title":"Immunobiology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: Partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33698","article-title":"Caspase-8: A key protein of cross-talk signal way in \u201cPANoptosis\u201d in cancer","volume":"149","author":"Jiang","year":"2021","journal-title":"Int J Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J Mol Biol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discovery"},{"key":"B52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2476-2","article-title":"Chemotherapy-induced pyroptosis is mediated by BAK\/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00971","article-title":"Induction of pyroptosis and its implications in cancer management","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3040-2_11","article-title":"Detection of gasdermin C-mediated cancer cell pyroptosis","volume-title":"Pyroptosis: Methods and Protocols","author":"Hou","year":"2023"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau2818","article-title":"Pathogen blockade of TAK1 triggers caspase-8\u2013dependent cleavage of gasdermin D and cell death","volume":"362","author":"Orning","year":"2018","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-021-00506-9","article-title":"The metabolite \u03b1-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8","volume":"31","author":"Zhang","year":"2021","journal-title":"Cell Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aax7969","article-title":"Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome","volume":"5","author":"Liu","year":"2020","journal-title":"Sci Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/iai.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infection Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/biology9010021","article-title":"Apoptotic bodies: particular extracellular vesicles involved in intercellular communication","volume":"9","author":"Battistelli","year":"2020","journal-title":"Biology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-67171-6_4","article-title":"Apoptotic bodies: mechanism of formation, isolation and functional relevance","volume":"97","author":"Santavanond","year":"2021","journal-title":"Subcell Biochem"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.21.1.165","article-title":"Cell death: Apoptosis versus necrosis (Review)","volume":"21","author":"Kanduc","year":"2002","journal-title":"Int J Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D\u2019Arcy","year":"2019","journal-title":"Cell Biol Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/path.5248","article-title":"The pathological features of regulated necrosis","volume":"247","author":"Tonnus","year":"2019","journal-title":"J Pathol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.141.8.2629","article-title":"Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis","volume":"141","author":"Laster","year":"1988","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12771","article-title":"Inflammasome-associated cell death: Pyroptosis, apoptosis, and physiological implications","volume":"64","author":"Tsuchiya","year":"2020","journal-title":"Microbiol Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","article-title":"Pyroptosis versus necroptosis: similarities, differences, and crosstalk","volume":"26","author":"Frank","year":"2019","journal-title":"Cell Death Differ"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305538110","article-title":"Two independent pathways of regulated necrosis mediate ischemia\u2013reperfusion injury","volume":"110","author":"Linkermann","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu146","article-title":"RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction","volume":"103","author":"Luedde","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat Chem Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi J, Zhao Y, Wang K","year":"2015","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.05.020","article-title":"Caspases in cell death, inflammation, and disease","volume":"50","author":"Van Opdenbosch","year":"2019","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101220-030653","article-title":"Inflammatory caspases: toward a unified model for caspase activation by inflammasomes","volume":"40","author":"Ross","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri.2015.7","article-title":"Converging roles of caspases in inflammasome activation, cell death and innate immunity","volume":"16","author":"Man","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010426","article-title":"Switching from apoptosis to pyroptosis: gasdermin-elicited inflammation and antitumor immunity","volume":"22","author":"Tsuchiya","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.842313","article-title":"Pyroptosis-related inflammasome pathway: A new therapeutic target for diabetic cardiomyopathy","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.33568","article-title":"Role of pyroptosis in cardiovascular diseases and its therapeutic implications","volume":"15","author":"Zeng","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107879","article-title":"Celastrol inhibits rheumatoid arthritis through the ROS-NF-\u03baB-NLRP3 inflammasome axis","volume":"98","author":"Jing","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.05.027","article-title":"Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-\u03baB activation","volume":"17","author":"Zhao","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000452","article-title":"Chlorogenic Acid Suppresses miR-155 and Ameliorates Ulcerative Colitis through the NF-\u03baB\/NLRP3 Inflammasome Pathway","volume":"64","author":"Zeng","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107728","article-title":"Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4\/NF-\u03baB\/NLRP3 and PGC1a\/SIRT3 pathways","volume":"96","author":"Yao","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.21037\/apm-19-516","article-title":"Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice","volume":"10","author":"Xu","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1082497","DOI":"10.1155\/2019\/1082497","article-title":"Astragaloside IV suppresses high glucose-induced NLRP3 inflammasome activation by inhibiting TLR4\/NF-\u03baB and caSR","volume":"2019","author":"Leng","year":"2019","journal-title":"Mediators Inflamm"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1159\/000453208","article-title":"Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4\/NF-\u03baB pathway in H9c2 cells","volume":"40","author":"Huang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5853238","article-title":"Oxidative stress and inflammation in cardiovascular disease","volume":"2017","author":"Garc\u00eda","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13743","article-title":"Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080765","article-title":"TXNIP\/TBP-2: A master regulator for glucose homeostasis","volume":"9","author":"Yoshihara","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"B94","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","article-title":"Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis","volume":"16","author":"Han","year":"2018","journal-title":"Redox Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10557-013-6498-1","article-title":"Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model","volume":"28","author":"Luo","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768029","article-title":"MiR-17-5p inhibits TXNIP\/NLRP3 inflammasome pathway and suppresses pancreatic \u03b2-cell pyroptosis in diabetic mice","volume":"8","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/etm.2021.10110","article-title":"Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review)","volume":"22","author":"Wu","year":"2021","journal-title":"Exp Ther Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5913374","article-title":"Oxidative stress signaling mediated pathogenesis of diabetic cardiomyopathy","volume":"2022","author":"Tang","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9723632","article-title":"Quercetin inhibits pyroptosis in diabetic cardiomyopathy through the nrf2 pathway","volume":"2022","author":"Wei","year":"2022","journal-title":"J Diabetes Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"152774","DOI":"10.1016\/j.phymed.2018.11.034","article-title":"Luteolin protects against diabetic cardiomyopathy by inhibiting NF-\u03baB-mediated inflammation and activating the Nrf2-mediated antioxidant responses","volume":"59","author":"Li","year":"2019","journal-title":"Phytomedicine"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3906043","article-title":"Curcumin improves diabetic cardiomyopathy by inhibiting pyroptosis through AKT\/nrf2\/ARE pathway","volume":"2023","author":"Wei","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0331-x","article-title":"Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine","volume":"17","author":"Karbassi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ctm2.13","article-title":"NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Trans Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.934255","article-title":"Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling","volume":"28","author":"Shen","year":"2022","journal-title":"Med Sci Monitor: Int Med J Exp Clin Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.879232","article-title":"Farrerol alleviates myocardial ischemia\/reperfusion injury by targeting macrophages and NLRP3","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S373962","article-title":"P2X7R-NEK7-NLRP3 inflammasome activation: A novel therapeutic pathway of qishen granule in the treatment of acute myocardial ischemia","volume":"15","author":"Li","year":"2022","journal-title":"JIR"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97054","article-title":"CaMKII\u03b4-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis","volume":"3","author":"Willeford","year":"2018","journal-title":"JCI Insight"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by ca2+\/calmodulin-dependent protein kinase II \u03b4 Signaling in cardiomyocytes are essential for adverse cardiac remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00223.2019","article-title":"Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling","volume":"317","author":"Suetomi","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3790721","article-title":"The role of NLRP3 inflammasome in diabetic cardiomyopathy and its therapeutic implications","volume":"2022","author":"Ding","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2020.1831245","article-title":"LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p\/AHR","volume":"19","author":"Xu","year":"2020","journal-title":"Cell Cycle"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.906548","article-title":"Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00381","article-title":"Chemerin\/CMKLR1 axis promotes inflammation and pyroptosis by activating NLRP3 inflammasome in diabetic cardiomyopathy rat","volume":"11","author":"Xie","year":"2020","journal-title":"Front Physiol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MA0821-418R","article-title":"Kakonein restores hyperglycemia-induced macrophage digestion dysfunction through regulation of cathepsin B-dependent NLRP3 inflammasome activation","volume":"112","author":"Lian","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00541-3","article-title":"Macrophages and the maintenance of homeostasis","volume":"18","author":"Mosser","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-020-00544-0","article-title":"Macrophage-NLRP3 inflammasome activation exacerbates cardiac dysfunction after ischemic stroke in a mouse model of diabetes","volume":"36","author":"Lin","year":"2020","journal-title":"Neurosci Bull"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030970","article-title":"The diabetic cardiac fibroblast: mechanisms underlying phenotype and function","volume":"21","author":"Levick","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i6.860","article-title":"Molecular mechanisms of AGE\/RAGE-mediated fibrosis in the diabetic heart","volume":"5","author":"Zhao","year":"2014","journal-title":"World J Diabetes"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.806966","article-title":"Ranolazine Inhibits Pyroptosis via Regulation of miR-135b in the Treatment of Diabetic Cardiac Fibrosis","volume":"9","author":"Ren","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1029-4","article-title":"Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","article-title":"Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy","volume":"40","author":"Knapp","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"B125","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis"},{"key":"B126","doi-asserted-by":"publisher","first-page":"16550","DOI":"10.1038\/s41598-023-43786-4","article-title":"Polydatin improves vascular endothelial function by maintaining mitochondrial homeostasis under high glucose conditions","volume":"13","author":"Shah","year":"2023","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41420-021-00606-w","article-title":"Microtubule associated protein 4 (MAP4) phosphorylation reduces cardiac microvascular density through NLRP3-related pyroptosis","volume":"7","author":"Feng","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10079-9","article-title":"SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms","volume":"27","author":"Nikolic","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01816-5","article-title":"Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms","volume":"22","author":"Huang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1042\/CS20190585","article-title":"Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice","volume":"133","author":"Xue","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-06978-y","article-title":"Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK-mTOR interplay","volume":"34","author":"Chen","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.29680","article-title":"Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00425","article-title":"Metformin ameliorates diabetic cardiomyopathy by activating the PK2\/PKR pathway","volume":"11","author":"Yang","year":"2020","journal-title":"Front Physiol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2022.03.010","article-title":"Co-administration of hydrogen and metformin exerts cardioprotective effects by inhibiting pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"183","author":"Zou","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11020432","article-title":"Supplementation with a cocoa-carob blend, alone or in combination with metformin, attenuates diabetic cardiomyopathy, cardiac oxidative stress and inflammation in zucker diabetic rats","volume":"11","author":"Garc\u00eda-D\u00edez","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2669","article-title":"Combination of dendrobium mixture and metformin curbs the development and progression of diabetic cardiomyopathy by targeting the lncRNA NEAT1","volume":"76","author":"Qin","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"80","DOI":"10.12307\/2023.773","article-title":"Dapagliflozin attenuates endothelial cell pyroptosis and dysfunction induced by oxidized low-density lipoprotein","volume":"28","author":"Quanwei","year":"2024","journal-title":"Chin J Tissue Eng Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202143","article-title":"Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B141","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108595","article-title":"MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes","volume":"106","author":"Bakhshi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat Chem Biol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2021.104265","article-title":"Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy","volume":"139","author":"Ge","year":"2022","journal-title":"Microvasc Res"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2337\/db20-0357","article-title":"Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis","volume":"70","author":"Sharma","year":"2021","journal-title":"Diabetes"},{"key":"B146","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12974-019-1498-0","article-title":"NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes","volume":"16","author":"Hong","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1210","article-title":"Biochemical and structural aspects of the ATP-binding domain in inflammasome-forming human NLRP proteins","volume":"65","author":"MacDonald","year":"2013","journal-title":"IUBMB Life"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220922104654","article-title":"The selective NLRP3-inflammasome inhibitor CY-09 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3- inflammasome activation","volume":"30","author":"Yang","year":"2023","journal-title":"Curr Med Chem"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-020-04571-8","article-title":"Sleeve gastroplasty combined with the NLRP3 inflammasome inhibitor CY-09 reduces body weight, improves insulin resistance and alleviates hepatic steatosis in mouse model","volume":"30","author":"Sun","year":"2020","journal-title":"Obes Surg"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14510","article-title":"Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","article-title":"MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics","volume":"20","author":"Jakubik","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.03.013","article-title":"Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention","volume":"1863","author":"Guo","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117980","article-title":"Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy","volume":"256","author":"Xu","year":"2020","journal-title":"Life Sci"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.430","article-title":"MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8864","article-title":"miR-223-3p reduces high glucose and high fat-induced endothelial cell injury in diabetic mice by regulating NLRP3 expression","volume":"20","author":"Deng","year":"2020","journal-title":"Exp Ther Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B158","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","article-title":"CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105094","article-title":"The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis","volume":"22","author":"Jubaidi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1166653","article-title":"Pomegranate peel extract protects against the development of diabetic cardiomyopathy in rats by inhibiting pyroptosis and downregulating LncRNA-MALAT1","volume":"14","author":"Abo-Saif","year":"2023","journal-title":"Front Pharmacol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16798","article-title":"Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy","volume":"25","author":"Li","year":"2021","journal-title":"J Cell Mol Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1322907\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:31:23Z","timestamp":1704429083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1322907\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":162,"alternative-id":["10.3389\/fendo.2023.1322907"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1322907","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1322907"}}